Assessment of Myocardial Injury in Simultaneous Pancreas and Kidney Transplantation — AMI-SPK

Diabetic Cardiomyopathy Clinical Trial

Official title:
Assessment of Myocardial Injury in Recipients of Simultaneous Pancreas and Kidney Transplantation

Status Active, not recruiting

Clinical Trial Summary

Diabetic cardiomyopathy( DCM) is a major complication of diabetes and is a common cardiovascular complication independent of coronary artery disease and hypertension．Trial to assess of myocardial injury in recipients of simultaneous pancreas and kidney transplantation by nuclear magnetic T２ mapping technology.

Clinical Trial Description

1. Evaluate the changes of myocardial injury before and after SPK by cardiac magnetic resonance imaging (CMR),

2. Evaluate the value of SPK in the repair of myocardial injury by comparing with the single renal transplant in recipients with diabetic nephropathy. ;

Study Design

Related Conditions & MeSH terms

Cardiomyopathies
Diabetic Cardiomyopathies
Diabetic Cardiomyopathy
Simultaneous Pancreas-kidney Transplantation

Clinical Trial Details

NCT number	NCT03904485
Study type	Observational
Source	Tianjin First Central Hospital
Contact
Status	Active, not recruiting
Phase
Start date	April 1, 2019
Completion date	April 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT00628056` - Mechanisms Responsible for Cardiac and Skeletal Muscle Energetic Impairment in Diabetes	Phase 1/Phase 2
Completed	`NCT01803828` - REmodelling in Diabetic CardiOmapathy: Gender Response to PDE5i InhibiTOrs	Phase 4
Completed	`NCT05102851` - Impact of Prediabetes on Acute Coronary Syndrome